Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 2 滋肾壮骨片治疗原发性骨质疏松症(肝肾不足伴血瘀证) 有效性和安全性随机双盲、平行对照、多中心II期临床研究
[Translation] A randomized, double-blind, parallel-controlled, multicenter phase II clinical study on the efficacy and safety of Zishen Zhuanggu Tablets in the treatment of primary osteoporosis (liver and kidney deficiency with blood stasis syndrome)
1.客观评价滋肾壮骨片的安全性;
2.客观评价滋肾壮骨片治疗原发性骨质疏松症中医辨证属肝肾不足伴血瘀证候者的临床疗效。
[Translation] 1. Objectively evaluate the safety of Zishen Zhuanggu Tablets;
2. Objectively evaluate the clinical efficacy of Zishen Zhuanggu Tablets in the treatment of primary osteoporosis in patients with liver and kidney deficiency and blood stasis syndrome according to TCM differentiation.
100 Clinical Results associated with Guangzhou Haojiandan Medicine Research & Development Co., Ltd.
0 Patents (Medical) associated with Guangzhou Haojiandan Medicine Research & Development Co., Ltd.
100 Deals associated with Guangzhou Haojiandan Medicine Research & Development Co., Ltd.
100 Translational Medicine associated with Guangzhou Haojiandan Medicine Research & Development Co., Ltd.